98 related articles for article (PubMed ID: 32262891)
1. Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductase.
He L; Ji S; Lai H; Chen T
J Mater Chem B; 2015 Nov; 3(42):8383-8393. PubMed ID: 32262891
[TBL] [Abstract][Full Text] [Related]
2. Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways.
Lai H; Fu X; Sang C; Hou L; Feng P; Li X; Chen T
Chem Asian J; 2018 Jun; 13(11):1447-1457. PubMed ID: 29575811
[TBL] [Abstract][Full Text] [Related]
3. Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics.
Liu X; Yuan Z; Tang Z; Chen Q; Huang J; He L; Chen T
Biomater Sci; 2021 Jul; 9(13):4691-4700. PubMed ID: 34019044
[TBL] [Abstract][Full Text] [Related]
4. Dual-function nanosystem for synergetic cancer chemo-/radiotherapy through ROS-mediated signaling pathways.
He L; Lai H; Chen T
Biomaterials; 2015 May; 51():30-42. PubMed ID: 25770995
[TBL] [Abstract][Full Text] [Related]
5. Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells.
Liang YW; Zheng J; Li X; Zheng W; Chen T
Eur J Med Chem; 2014 Sep; 84():335-42. PubMed ID: 25036792
[TBL] [Abstract][Full Text] [Related]
6. Rational Design of Cancer-Targeted Selenadiazole Derivative as Efficient Radiosensitizer for Precise Cancer Therapy.
Zeng D; Deng S; Sang C; Zhao J; Chen T
Bioconjug Chem; 2018 Jun; 29(6):2039-2049. PubMed ID: 29771500
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways.
Xie Q; Zhou Y; Lan G; Yang L; Zheng W; Liang Y; Chen T
Biochem Biophys Res Commun; 2014 Jun; 449(1):88-93. PubMed ID: 24813998
[TBL] [Abstract][Full Text] [Related]
8. Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking P53 activation.
Xu Y; Lai H; Pan S; Pan L; Liu T; Yang Z; Chen T; Zhu X
Biomaterials; 2024 Mar; 305():122452. PubMed ID: 38154440
[TBL] [Abstract][Full Text] [Related]
9. Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways.
Yang Y; Deng S; Zeng Q; Hu W; Chen T
Dalton Trans; 2016 Nov; 45(46):18465-18475. PubMed ID: 27711726
[TBL] [Abstract][Full Text] [Related]
10. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
[TBL] [Abstract][Full Text] [Related]
11. Rational design of selenadiazole derivatives to antagonize hyperglycemia-induced drug resistance in cancer cells.
Liu Y; Luo Y; Li X; Zheng W; Chen T
Chem Asian J; 2015 Mar; 10(3):642-52. PubMed ID: 25641920
[TBL] [Abstract][Full Text] [Related]
12. Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways.
Zhao J; Zeng D; Liu Y; Luo Y; Ji S; Li X; Chen T
Metallomics; 2017 May; 9(5):535-545. PubMed ID: 28374040
[TBL] [Abstract][Full Text] [Related]
13. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
14. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
[TBL] [Abstract][Full Text] [Related]
16. Molybdenum disulfide-based hyaluronic acid-guided multifunctional theranostic nanoplatform for magnetic resonance imaging and synergetic chemo-photothermal therapy.
Liu J; Zheng J; Nie H; Zhang D; Cao D; Xing Z; Li B; Jia L
J Colloid Interface Sci; 2019 Jul; 548():131-144. PubMed ID: 30991180
[TBL] [Abstract][Full Text] [Related]
17. Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway.
Liang Y; Zhou Y; Deng S; Chen T
ChemMedChem; 2016 Oct; 11(20):2339-2346. PubMed ID: 27677422
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
19. EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells.
Shao FY; Wang S; Li HY; Chen WB; Wang GC; Ma DL; Wong NS; Xiao H; Liu QY; Zhou GX; Li YL; Li MM; Wang YF; Liu Z
Oncotarget; 2016 Feb; 7(6):6790-808. PubMed ID: 26758418
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase.
Luo Z; Yu L; Yang F; Zhao Z; Yu B; Lai H; Wong KH; Ngai SM; Zheng W; Chen T
Metallomics; 2014 Aug; 6(8):1480-90. PubMed ID: 24823440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
